Cancer Home > Geftinib
Were you looking for information about Gefitinib? Geftinib is a common misspelling of gefitinib.
Gefitinib (Iressa®) is a drug approved for the treatment of non-small cell lung cancer in adults age 18 and older. It is available by prescription only and comes as a tablet taken once daily.
Before you begin treatment with this chemotherapy drug, your healthcare provider will want to know if you have liver disease, are pregnant or breastfeeding, or have any allergies. Potential side effects of gefitinib include diarrhea, a rash, and nausea.
(Click Gefitinib for a closer look at this chemotherapy drug, including how it works, who makes it, safety precautions, and more. You can also click any of the links in the box to the right for specific information.)